Age-specific Comparative Clinical Outcomes of Chemonucleolysis with Condoliase versus Microendoscopic Discectomy in Patients with Lumbar Disc Herniation

腰椎间盘突出症患者接受Condoliase化学溶解术与微创内镜椎间盘切除术的年龄特异性临床疗效比较

阅读:1

Abstract

INTRODUCTION: Condoliase-based chemonucleolysis and microendoscopic discectomy (MED) are considered to be minimally invasive treatments for lumbar disc herniation (LDH). The aim of this study was to compare the clinical outcomes of both treatments, specifically focusing on whether the outcomes vary by age group. METHODS: Patients with LDH who received intradiscal condoliase injections (condoliase group) or underwent MED (MED group) with 1-year follow-up were enrolled in this study. A numerical rating scale (NRS) was developed for leg and back pains. Using magnetic resonance imaging, changes in disc height and degeneration were evaluated. The data were assessed at baseline and at 3-month and 1-year follow-ups. The therapy was considered effective in patients whose NRS for leg pain improved by ≥50% at 1 year from baseline and for whom surgery was not required. Comparative analyses were conducted between the condoliase and MED groups and among the <20, 20-39, 40-59, and ≥60 year age groups. RESULTS: In this study, a total of 345 patients (condoliase group, n=233; MED group, n=112) were enrolled. Subsequent surgery was required in 23 patients (9.9%) in the condoliase group because of the ineffectiveness of the condoliase therapy. Because of herniation recurrence, reoperation was required in five patients (4.5%) in the MED group. The efficacy rates were respectively 74.4% and 74.6% in the condoliase and MED groups, and no intergroup or age-group differences were found. The condoliase group had a significantly higher decrease in disc height when compared with the MED group (9.0% vs. 4.4%, p<0.05). Compared with the older age group, the younger age group had a greater decrease in disc height and disc degeneration; however, their recovery was better than that of the older age group. Among the age groups, the herniation reduction rate did not significantly vary. CONCLUSIONS: Condoliase and MED had equivalent 1-year outcomes, with no differences observed in efficacy across age groups. For informed decision-making, the advantages and disadvantages of each treatment must be understood.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。